Skip to Main Content

Paper Details

PharmGKB summary: sorafenib pathways.
Pharmacogenet Genomics
39
2017
Author NameAffiliation
Li GongDepartments of aBiomedical Data Science bBiomedical Engineering cGenetics Stanford University, California fInova Schar Cancer Institute and Therapeutics, Center for Personalized Health
  • 1 - 1

Datasets

PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink
PharmGKBVariation in drug response based on human variationLink